Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bulk tissue RNA sequencing from human donors with and without lung fibrosis

ABSTRACT: Bulk tissue RNA sequencing from human donors with and without lung fibrosis

PROVIDER: PRJNA878759 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21498200.fastq.gz	Fastqsanger.gz
	SRR21498300.fastq.gz	Fastqsanger.gz
	SRR21498400.fastq.gz	Fastqsanger.gz
	SRR21498500.fastq.gz	Fastqsanger.gz
	SRR21498600.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 695

Similar Datasets

Bulk tissue RNA sequencing from human donors with and without lung fibrosis

Project description:Idiopathic pulmonary fibrosis (IPF) is a lethal fibrotic lung condition with an unpredictable disease course. The pathology of IPF starts in the lung bases such that a patient’s lung apices are comparatively less fibrotic at the time of transplantation. We hypothesized that RNA sequencing of the lung apices and bases may identify differentially expressed genes that better reflect disease progression in IPF. Samples were derived from both right and left lungs when available and RNA Seq was performed on a total of 139 samples.

2022-11-02 | GSE213001 | GEO

Bulk RNAseq analysis of Cx3cr1+ macrophages with and without IL4Ra deletion during bleomycin-induced lung fibrosis.

Project description:Bulk RNAseq analysis of Cx3cr1+ macrophages with and without IL4Ra deletion during bleomycin-induced lung fibrosis.

| PRJNA1135117 | ENA

GNPS-Cystic Fibrosis Lung Tissue Patient1

Project description:Left human lung associated with cystic fibrosis was sectioned in to small cubes and analyzed by sequencing and mass spectrometry

2016-04-15 | MSV000079652 | GNPS

Bulk RNA-seq of aplastic anemia (AA) and healthy donors

Project description:Bulk RNA-seq data of Lin-CD34+ hematopoietic stem and progenitor cells derived from bone marrow of healthy donors and untreated aplastic anemia patients

2021-03-31 | GSE165870 | GEO

Comprehensive bulk RNAseq analysis on whole kidneys during regeneration and fibrosis development reveals sustained dysregulation of immune system related pathways during kidney fibrosis

Project description:In order to identify the transcriptional changes that correlate with kidney regeneration or fibrosis development, we performed a time-course bulk RNA-seq from whole-kidneys at 3, 7, 14, 28 and 42 days after the initial ischemic kidney from two distinct murine models.

2020-01-31 | E-MTAB-7957 | biostudies-arrayexpress

Spatial transcriptomics (Visium, 10x Genomics) data for human Idiopathic Pulmonary Fibrosis (IPF) and control lung tissue

Project description:Visium (10x Genomics) spatially resolved transcriptomics data generated from normal and Idiopathic Pulmonary Fibrosis (IPF) lung parenchyma tissues collected from human donors. The fresh-frozen tissues that were analyzed were from four healthy control (HC) subjects and from four IPF patients. For each IPF patient, three different tissues were selected representing areas of mild (“B1”), moderate (“B2\") or severe (“B3”) fibrosis within the same donor, as determined by histological inspection of Hematoxylin and Eosin (H&E)-stained samples. Data from a total of 25 tissue sections, from 16 unique lung tissue blocks. The lung tissues were collected post-mortem (HC donors) or during lung transplant/resection (IPF patients) after obtaining informed consent. The study protocols were approved by the local human research ethics committee (HC: Lund, permit number Dnr 2016/317; IPF: Gothenburg, permit number 1026-15) and the samples are anonymized and cannot/should not be traced back to individual donors.

2024-05-28 | E-MTAB-14121 | biostudies-arrayexpress

Lung transplant survival in pulmonary fibrosis with telomere dysfunction

Project description:Lung transplant outcomes in pulmonary fibrosis with and without telomere dysfunction

2021-07-22 | PRJEB46414 | EVA

Mesenchymal cell type-specific roles of KLF4 in lung fibrosis [bulk RNA-seq]

Project description:Purpose: The goal of this study is to investigate mesenchymal cell-type specific role of KLF4 in the context of lung fibrosis. Methods: Adult Pdgfrb-CreERT2, ROSA26R(Zs/+) mice were induced with tamoxifen (1mg/day for 5 days), rested for 5 days. The lungs were harvested and prepared to obtain single cell suspension. Live Zs+ cells were isolated by FACS, cultured, and subjected to Klf4 siRNA or Scr RNA treatment. Total RNA was purified after 72 hrs. and subjected to bulk RNA-seq. using Illumina HiSeq 2000. Similarly, wild type mice airway smooth muscle cells (cell biologics) were treated with Klf4 siRNA or Scr RNA. Total RNA was purified after 72 hrs. and subjected to bulk RNA-seq. Results: Expression profile of the transcriptome are compared between cell-types; PDGFR-β+ cells and airway smooth muscle cells. Conclusions: Significant difference in the expression of genes involved in pathogenesis of fibrosis was observed

2021-09-23 | GSE184670 | GEO

Effects of ginkgetin on liver fibrosis by bulk RNA Sequencing

Project description:Ginkgetin could significantly attenuate liver fibrosis in a mouse model induced by TAA, including inhibiting hepatic inflammtion and fibrosis. In addition, the related signaling pathways and gene expression were also downregulated by ginkgetin by bulk RNA Sequencing analysis.

2023-08-03 | GSE236779 | GEO

Bulk RNA-seq of human engineered heart tissue for analyzing human myocardial fibrosis

Project description:Myocardial infarction models developed to understand fibrosis and promote myocardial regeneration towards ischemic heart disease (IHD) is challenged due to the low-throughput nature of in vivo models and the lack of humanized cardiac scarring in the in vitro models. We generated a novel 4D cardiac scarring model (4DCSM) mimicking the IHD in vitro based on the human engineered heart tissue(hEHT). To identify potential signaling dominating the fibrotic process, we characterized transcriptomics of 4DCSM at different scarring stages by bulk RNA sequencing. Taken together, our dataset is an informative resource to reveal the potential signaling dominating the fibrotic process and provides potential comparisons with public clinical data cohorts or other MI fibrosis model data.

2023-06-14 | GSE234715 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data